New antibody combo tested for tough cancers
Disease control
Completed
This early-phase study tested a new experimental drug called HMBD-002, alone or with another cancer drug (pembrolizumab), in 48 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see …
Phase: PHASE1 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 15, 2026 11:54 UTC